Literature DB >> 10961918

Expression of recombinant human type I-III collagens in the yeast pichia pastoris.

J Myllyharju1, M Nokelainen, A Vuorela, K I Kivirikko.   

Abstract

An efficient expression system for recombinant human collagens will have numerous scientific and medical applications. However, most recombinant systems are unsuitable for this purpose, as they do not have sufficient prolyl 4-hydroxylase activity. We have developed methods for producing the three major fibril-forming human collagens, types I, II and III, in the methylotrophic yeast Pichia pastoris. These methods are based on co-expression of procollagen polypeptide chains with the alpha- and beta-subunits of prolyl 4-hydroxylase. The triple-helical type-I, -II and-III procollagens were found to accumulate predominantly within the endoplasmic reticulum of the yeast cells and could be purified from the cell lysates by a procedure that included a pepsin treatment to convert the procollagens into collagens and to digest most of the non-collagenous proteins. All the purified recombinant collagens were identical in 4-hydroxyproline content with the corresponding non-recombinant human proteins, and all the recombinant collagens formed native-type fibrils. The expression levels using single-copy integrants and a 2 litre bioreactor ranged from 0.2 to 0.6 g/l depending on the collagen type.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961918

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

Review 1.  Collagens as biomaterials.

Authors:  John A M Ramshaw; Yong Y Peng; Veronica Glattauer; Jerome A Werkmeister
Journal:  J Mater Sci Mater Med       Date:  2008-04-01       Impact factor: 3.896

2.  Natural and Genetically Engineered Proteins for Tissue Engineering.

Authors:  Sílvia Gomes; Isabel B Leonor; João F Mano; Rui L Reis; David L Kaplan
Journal:  Prog Polym Sci       Date:  2012-01-01       Impact factor: 29.190

3.  Tunable, post-translational hydroxylation of collagen Domains in Escherichia coli.

Authors:  Daniel M Pinkas; Sheng Ding; Ronald T Raines; Annelise E Barron
Journal:  ACS Chem Biol       Date:  2011-01-14       Impact factor: 5.100

Review 4.  Production of protein-based polymers in Pichia pastoris.

Authors:  Marc W T Werten; Gerrit Eggink; Martien A Cohen Stuart; Frits A de Wolf
Journal:  Biotechnol Adv       Date:  2019-03-19       Impact factor: 14.227

5.  The collagen V homotrimer [alpha1(V)](3) production is unexpectedly favored over the heterotrimer [alpha1(V)](2)alpha2(V) in recombinant expression systems.

Authors:  Muriel Roulet; Merja Välkkilä; Hélène Chanut-Delalande; Eija-Riitta Hämäläinen; Efrat Kessler; Leena Ala-Kokko; Minna Männikkö; Christelle Bonod-Bidaud; Florence Ruggiero
Journal:  J Biomed Biotechnol       Date:  2010-06-27

6.  Missense mutations that cause Bruck syndrome affect enzymatic activity, folding, and oligomerization of lysyl hydroxylase 2.

Authors:  Marjo Hyry; Juha Lantto; Johanna Myllyharju
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

7.  Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice.

Authors:  Kati Rautavuoma; Kati Takaluoma; Raija Sormunen; Johanna Myllyharju; Kari I Kivirikko; Raija Soininen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

8.  Expression of a recombinant elastin-like protein in pichia pastoris.

Authors:  Rory E Sallach; Vincent P Conticello; Elliot L Chaikof
Journal:  Biotechnol Prog       Date:  2009 Nov-Dec

9.  Improved production of human type II procollagen in the yeast Pichia pastoris in shake flasks by a wireless-controlled fed-batch system.

Authors:  Maria Ruottinen; Monika Bollok; Martin Kögler; Antje Neubauer; Mirja Krause; Eija-Riitta Hämäläinen; Johanna Myllyharju; Antti Vasala; Peter Neubauer
Journal:  BMC Biotechnol       Date:  2008-03-27       Impact factor: 2.563

Review 10.  Marine origin collagens and its potential applications.

Authors:  Tiago H Silva; Joana Moreira-Silva; Ana L P Marques; Alberta Domingues; Yves Bayon; Rui L Reis
Journal:  Mar Drugs       Date:  2014-12-05       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.